MedTech to Watch
2024
Cardiovascular

Pulsed field ablation

Cardiovascular -
Pulsed field ablation

Where is the market heading for treating atrial fibrillation?
Pulsed field ablation (PFA) has emerged as a promising treatment for atrial fibrillation (AF), garnering significant attention from the cardiac ablation community. Pulsed field ablation employs electric pulses, not heat, that help in electroporation of the myocardium without collateral damage to normal heart tissue. Compared to established treatment options, PFA has remarkably low recurrence
rates, shorter treatment durations and higher success rates.

This report answers key questions around the rapidly evolving market for PFA: 
  • Why is pulsed field ablation a medical technology to watch   
  • How will PFA impact the electrophysiology mapping and ablation market?    
  • What gaps in treatment does PFA fill?    
  • What hurdles will PFA face in terms of adoption?  
60 M people worldwide are affected by AF
The PFA market is projected to reach $3bn by 2028.
This report is a preview of the full MedTech to Watch 2024 whitepaper
Learn more about our Medtech intelligence solutions

Complete this form to download the PFA report.

HIDDEN FIELDS BELOW

“Due to the ease of access and the variety of content and formats available, ExLibris will enable our academic community to access information that produces better outcomes.”

Tomomi Asano, Manager of the Public Service Group at International Christian University Library

“Due to the ease of access and the variety of content and formats available, ExLibris will enable our academic community to access information that produces better outcomes.”

Tomomi Asano, Manager of the Public Service Group at International Christian University Library

“Due to the ease of access and the variety of content and formats available, ExLibris will enable our academic community to access information that produces better outcomes.”

Tomomi Asano, Manager of the Public Service Group at International Christian University Library